Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4269/ajtmh.14-0535 http://scihub22266oqcxt.onion/10.4269/ajtmh.14-0535 C4455073!4455073!25897073     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Trop+Med+Hyg 2015 ; 92 (Suppl 6): 68-74 Nephropedia Template TP {{tp|p=25897073|t=2015. Monitoring the Quality of Medicines: Results from Africa, Asia, and South America |pdf=|usr=}}{{25897073}} gab.com Text Monitoring the Quality of Medicines: Results from Africa, Asia, and South America JO: Am J Trop Med Hyg http://www.kidney.de/pget.php?&tw=1&pmid=25897073 #FOAvip Monitoring the quality of medicines plays a crucial role in an integrated medicines quality assurance system. In a publicly available medicines quality database (MQDB), the U.S. Pharmacopeial Convention (USP) reports results of data collected from medicines quality monitoring (MQM) activities spanning the period of 2003?2013 in 17 countries of Africa, Asia, and South America. The MQDB contains information on 15,063 samples collected and tested using Minilab® screening methods and/or pharmacopeial methods. Approximately 71% of the samples reported came from Asia, 23% from Africa, and 6% from South America. The samples collected and tested include mainly antibiotic, antimalarial, and antituberculosis medicines. A total of 848 samples, representing 5.6% of total samples, failed the quality test. The failure proportion per region was 11.5%, 10.4%, and 2.9% for South America, Africa, and Asia, respectively. Eighty-one counterfeit medicines were reported, 86.4% of which were found in Asia and 13.6% in Africa. Additional analysis of the data shows the distribution of poor-quality medicines per region and by therapeutic indication as well as possible trends of counterfeit medicines. Twit Text FOAVip Monitoring the Quality of Medicines: Results from Africa, Asia, and South America ????Am J Trop Med Hyg http://www.kidney.de/pget.php?&tw=1&pmid=25897073 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25897073 #FOAvip English Wikipedia <ref>{{Cite pmid|25897073}}</ref> Monitoring the Quality of Medicines: Results from Africa, Asia, and South America #MMPMID25897073 Hajjou M; Krech L; Lane-Barlow C; Roth L; Pribluda VS; Phanouvong S; El-Hadri L; Evans L; Raymond C; Yuan E; Siv L; Vuong TA; Boateng KP; Okafor R; Chibwe KM; Lukulay PH Am J Trop Med Hyg 2015[Jun]; 92 (Suppl 6): 68-74 PMID25897073show ga Monitoring the quality of medicines plays a crucial role in an integrated medicines quality assurance system. In a publicly available medicines quality database (MQDB), the U.S. Pharmacopeial Convention (USP) reports results of data collected from medicines quality monitoring (MQM) activities spanning the period of 2003?2013 in 17 countries of Africa, Asia, and South America. The MQDB contains information on 15,063 samples collected and tested using Minilab® screening methods and/or pharmacopeial methods. Approximately 71% of the samples reported came from Asia, 23% from Africa, and 6% from South America. The samples collected and tested include mainly antibiotic, antimalarial, and antituberculosis medicines. A total of 848 samples, representing 5.6% of total samples, failed the quality test. The failure proportion per region was 11.5%, 10.4%, and 2.9% for South America, Africa, and Asia, respectively. Eighty-one counterfeit medicines were reported, 86.4% of which were found in Asia and 13.6% in Africa. Additional analysis of the data shows the distribution of poor-quality medicines per region and by therapeutic indication as well as possible trends of counterfeit medicines. äMonitoring the Quality of Medicines: Results from Africa, Asia, and So(epmc).pdf DeepDyve Pubget Overpricing